FMP

FMP

Enter

MYMD - MyMD Pharmaceuticals...

Financial Summary of MyMD Pharmaceuticals, Inc.(MYMD), MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developi

photo-url-https://financialmodelingprep.com/image-stock/MYMD.png

MyMD Pharmaceuticals, Inc.

MYMD

NASDAQ

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

1.82 USD

-0.01 (-0.549%)

About

ceo

Mr. Ian Rhodes CPA

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore...

CIK

0001321834

ISIN

US62856X2018

CUSIP

00973E409

Address

855 North Wolfe Street

Phone

856 848 8698

Country

US

Employee

6

IPO Date

Jan 23, 2014

Summary

CIK

0001321834

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

00973E409

ISIN

US62856X2018

Country

US

Price

1.82

Beta

2.69

Volume Avg.

61.81k

Market Cap

4.31M

Shares

-

52-Week

1.75-63.9

DCF

1.71

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.2

P/B

-

Website

https://www.mymd.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest MYMD News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep